Tzu‐Lan Yeh

448 total citations
7 papers, 173 citations indexed

About

Tzu‐Lan Yeh is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Tzu‐Lan Yeh has authored 7 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Organic Chemistry. Recurrent topics in Tzu‐Lan Yeh's work include Cancer, Hypoxia, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Epigenetics and DNA Methylation (2 papers). Tzu‐Lan Yeh is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Epigenetics and DNA Methylation (2 papers). Tzu‐Lan Yeh collaborates with scholars based in United Kingdom, United States and Germany. Tzu‐Lan Yeh's co-authors include Christopher J. Schofield, Anthony Tumber, Akane Kawamura, Martine I. Abboud, Giuseppe Scozzafava, Mun Chiang Chan, James R. Wickens, James McCullagh, Ganesha Rai and Christopher W. Pugh and has published in prestigious journals such as Chemical Communications, Scientific Reports and Chemistry - A European Journal.

In The Last Decade

Tzu‐Lan Yeh

7 papers receiving 168 citations

Peers

Tzu‐Lan Yeh
Travis Holloway United States
Hannah E. Greenwood United Kingdom
Christopher M. Russo United States
Jitendra K. Mishra India
Laura Neises Luxembourg
Eirinaios I. Vrettos Greece
Carlos A. Martinez United States
Takeru Ehara Japan
Chloe A. Briney United States
Ting-Huei Chen United States
Travis Holloway United States
Tzu‐Lan Yeh
Citations per year, relative to Tzu‐Lan Yeh Tzu‐Lan Yeh (= 1×) peers Travis Holloway

Countries citing papers authored by Tzu‐Lan Yeh

Since Specialization
Citations

This map shows the geographic impact of Tzu‐Lan Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tzu‐Lan Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tzu‐Lan Yeh more than expected).

Fields of papers citing papers by Tzu‐Lan Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tzu‐Lan Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tzu‐Lan Yeh. The network helps show where Tzu‐Lan Yeh may publish in the future.

Co-authorship network of co-authors of Tzu‐Lan Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Tzu‐Lan Yeh. A scholar is included among the top collaborators of Tzu‐Lan Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tzu‐Lan Yeh. Tzu‐Lan Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Holt‐Martyn, James P., Rasheduzzaman Chowdhury, Anthony Tumber, et al.. (2019). Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors. ChemMedChem. 15(3). 270–273. 25 indexed citations
2.
Fey, Kerstin, Christian R. Wick, Martine I. Abboud, et al.. (2018). A Fluorescent Benzo[g]isoquinoline‐Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging. ChemMedChem. 14(1). 94–99. 2 indexed citations
3.
Thinnes, Cyrille C., Christopher T. Lohans, Martine I. Abboud, et al.. (2018). Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding. Chemistry - A European Journal. 25(8). 2019–2024. 9 indexed citations
4.
McAllister, Tom E., Tzu‐Lan Yeh, Martine I. Abboud, et al.. (2018). Non-competitive cyclic peptides for targeting enzyme–substrate complexes. Chemical Science. 9(20). 4569–4578. 23 indexed citations
5.
Koukourakis, Michael I., Alexandra Giatromanolaki, Christos E. Zois, et al.. (2016). Normal tissue radioprotection by amifostine via Warburg-type effects. Scientific Reports. 6(1). 30986–30986. 29 indexed citations
6.
Thinnes, Cyrille C., Anthony Tumber, Clarence Yapp, et al.. (2015). Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases. Chemical Communications. 51(84). 15458–15461. 30 indexed citations
7.
Scozzafava, Giuseppe, Anthony Tumber, James R. Wickens, et al.. (2014). A Cell‐Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1. ChemMedChem. 9(3). 566–571. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Travis Holloway Breakdown of academic impact, for papers by Hannah E. Greenwood Breakdown of academic impact, for papers by Christopher M. Russo Breakdown of academic impact, for papers by Jitendra K. Mishra Breakdown of academic impact, for papers by Laura Neises Breakdown of academic impact, for papers by Eirinaios I. Vrettos Breakdown of academic impact, for papers by Carlos A. Martinez Breakdown of academic impact, for papers by Takeru Ehara Breakdown of academic impact, for papers by Chloe A. Briney Breakdown of academic impact, for papers by Ting-Huei Chen
Rankless by CCL
2026